{"id":"https://openalex.org/W2605481248","doi":"https://doi.org/10.1158/1535-7163.mct-17-0104","title":"Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells","display_name":"Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells","publication_year":2017,"publication_date":"2017-04-10","ids":{"openalex":"https://openalex.org/W2605481248","doi":"https://doi.org/10.1158/1535-7163.mct-17-0104","mag":"2605481248","pmid":"https://pubmed.ncbi.nlm.nih.gov/28396363"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-17-0104","doi":"https://doi.org/10.1158/1535-7163.mct-17-0104","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-17-0104","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041655493","display_name":"Pol Gim\u00e9nez\u2010Xavier","orcid":"https://orcid.org/0000-0003-1611-5083","observed_orcids":["https://orcid.org/0000-0003-1611-5083"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pol Gimenez-Xavier","raw_affiliation_strings":["1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029526644","display_name":"Eva Pros","orcid":"https://orcid.org/0000-0002-2366-7866","observed_orcids":["https://orcid.org/0000-0002-2366-7866"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eva Pros","raw_affiliation_strings":["1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031132324","display_name":"Ester Bonastre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ester Bonastre","raw_affiliation_strings":["1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057962012","display_name":"Sebasti\u00e1n Mor\u00e1n","orcid":"https://orcid.org/0000-0003-4192-8983","observed_orcids":["https://orcid.org/0000-0003-4192-8983"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sebastian Moran","raw_affiliation_strings":["2Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108803845","display_name":"Ana Aza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Aza","raw_affiliation_strings":["1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076376340","display_name":"Osvaldo Gra\u00f1a\u2010Castro","orcid":"https://orcid.org/0000-0003-1615-4242","observed_orcids":["https://orcid.org/0000-0003-1615-4242"]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Osvaldo Gra\u00f1a","raw_affiliation_strings":["3Bioinformatics Unit, Structural Biology and BioComputing Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Bioinformatics Unit, Structural Biology and BioComputing Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053487646","display_name":"Gonzalo Gom\u00e9z-L\u00f3pez","orcid":"https://orcid.org/0000-0002-4146-0551","observed_orcids":["https://orcid.org/0000-0002-4146-0551"]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gonzalo Gomez-Lopez","raw_affiliation_strings":["3Bioinformatics Unit, Structural Biology and BioComputing Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Bioinformatics Unit, Structural Biology and BioComputing Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012544868","display_name":"Sophia V. Derdak","orcid":"https://orcid.org/0000-0002-7544-3071","observed_orcids":["https://orcid.org/0000-0002-7544-3071"]},"institutions":[{"id":"https://openalex.org/I170486558","display_name":"Universitat Pompeu Fabra","ror":"https://ror.org/04n0g0b29","country_code":"ES","type":"education","lineage":["https://openalex.org/I170486558"]},{"id":"https://openalex.org/I4210132884","display_name":"Barcelona Institute of Science and Technology","ror":"https://ror.org/03kpps236","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210132884"]},{"id":"https://openalex.org/I4210137962","display_name":"Centre for Genomic Regulation","ror":"https://ror.org/03wyzt892","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210132884","https://openalex.org/I4210137962","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sophia Derdak","raw_affiliation_strings":["4CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain","5Universitat Pompeu Fabra (UPF), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain","institution_ids":["https://openalex.org/I4210132884","https://openalex.org/I4210137962"]},{"raw_affiliation_string":"5Universitat Pompeu Fabra (UPF), Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020261428","display_name":"Marc Dabad","orcid":"https://orcid.org/0000-0002-6094-747X","observed_orcids":["https://orcid.org/0000-0002-6094-747X"]},"institutions":[{"id":"https://openalex.org/I170486558","display_name":"Universitat Pompeu Fabra","ror":"https://ror.org/04n0g0b29","country_code":"ES","type":"education","lineage":["https://openalex.org/I170486558"]},{"id":"https://openalex.org/I4210132884","display_name":"Barcelona Institute of Science and Technology","ror":"https://ror.org/03kpps236","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210132884"]},{"id":"https://openalex.org/I4210137962","display_name":"Centre for Genomic Regulation","ror":"https://ror.org/03wyzt892","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210132884","https://openalex.org/I4210137962","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marc Dabad","raw_affiliation_strings":["4CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain","5Universitat Pompeu Fabra (UPF), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain","institution_ids":["https://openalex.org/I4210132884","https://openalex.org/I4210137962"]},{"raw_affiliation_string":"5Universitat Pompeu Fabra (UPF), Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015120537","display_name":"Anna Esteve\u2010Codina","orcid":"https://orcid.org/0000-0003-0361-2873","observed_orcids":["https://orcid.org/0000-0003-0361-2873"]},"institutions":[{"id":"https://openalex.org/I170486558","display_name":"Universitat Pompeu Fabra","ror":"https://ror.org/04n0g0b29","country_code":"ES","type":"education","lineage":["https://openalex.org/I170486558"]},{"id":"https://openalex.org/I4210132884","display_name":"Barcelona Institute of Science and Technology","ror":"https://ror.org/03kpps236","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210132884"]},{"id":"https://openalex.org/I4210137962","display_name":"Centre for Genomic Regulation","ror":"https://ror.org/03wyzt892","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210132884","https://openalex.org/I4210137962","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Anna Esteve-Codina","raw_affiliation_strings":["4CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain","5Universitat Pompeu Fabra (UPF), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain","institution_ids":["https://openalex.org/I4210132884","https://openalex.org/I4210137962"]},{"raw_affiliation_string":"5Universitat Pompeu Fabra (UPF), Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046826366","display_name":"Jos\u00e9 Ram\u00f3n Hern\u00e1ndez Mora","orcid":"https://orcid.org/0000-0001-6218-4544","observed_orcids":["https://orcid.org/0000-0001-6218-4544"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose R. Hernandez Mora","raw_affiliation_strings":["2Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091579157","display_name":"Diana Salinas-Chaparro","orcid":"https://orcid.org/0000-0002-3446-1783","observed_orcids":["https://orcid.org/0000-0002-3446-1783"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Diana Salinas-Chaparro","raw_affiliation_strings":["1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010137759","display_name":"Manel Esteller","orcid":"https://orcid.org/0000-0003-4490-6093","observed_orcids":["https://orcid.org/0000-0003-4490-6093"]},"institutions":[{"id":"https://openalex.org/I11932220","display_name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","ror":"https://ror.org/0371hy230","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I11932220"]},{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manel Esteller","raw_affiliation_strings":["2Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain","6Institucio Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039"]},{"raw_affiliation_string":"6Institucio Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Barcelona, Spain","institution_ids":["https://openalex.org/I11932220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079168682","display_name":"David G. Pisano","orcid":"https://orcid.org/0000-0002-4895-4124","observed_orcids":["https://orcid.org/0000-0002-4895-4124"]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"David Pisano","raw_affiliation_strings":["3Bioinformatics Unit, Structural Biology and BioComputing Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Bioinformatics Unit, Structural Biology and BioComputing Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076431300","display_name":"Montse S\u00e1nchez\u2010C\u00e9spedes","orcid":"https://orcid.org/0000-0002-6045-5627","observed_orcids":["https://orcid.org/0000-0002-6045-5627"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Montse Sanchez-Cespedes","raw_affiliation_strings":["1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.4966,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.93016094,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":98},"biblio":{"volume":"16","issue":"7","first_page":"1366","last_page":"1376"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7870000004768372},{"id":"https://openalex.org/keywords/met-inhibitors","display_name":"MET inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.8190000057220459},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9610000252723694},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.7250000238418579},{"id":"https://openalex.org/keywords/met-amplification","display_name":"MET amplification","score":0.6100000143051147},{"id":"https://openalex.org/keywords/dna-methylation","display_name":"DNA methylation","score":0.7670000195503235},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.6230000257492065},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.5239999890327454},{"id":"https://openalex.org/keywords/mutational-profiling","display_name":"mutational profiling","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7733625173568726},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7068827152252197},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.689530611038208},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5892376899719238},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.45170652866363525},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.44641953706741333},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4330858588218689},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.36388397216796875},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3223557770252228},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.24699851870536804},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16662505269050598},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.1508762240409851},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.10764074325561523}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019175","descriptor_name":"DNA Methylation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019859","descriptor_name":"Proto-Oncogene Proteins c-met","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019859","descriptor_name":"Proto-Oncogene Proteins c-met","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D023281","descriptor_name":"Genomics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D025581","descriptor_name":"Neurofibromin 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-17-0104","doi":"https://doi.org/10.1158/1535-7163.mct-17-0104","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-17-0104","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:28396363","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28396363","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324144","display_name":"National Institute of Biomedical Innovation","ror":"https://ror.org/001rkbe13"},{"id":"https://openalex.org/F4320330816","display_name":"National Institutes of Biomedical Innovation, Health and Nutrition","ror":null}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1971602395","https://openalex.org/W1980497534","https://openalex.org/W1983774108","https://openalex.org/W1985264867","https://openalex.org/W1986525211","https://openalex.org/W1987575156","https://openalex.org/W1990013637","https://openalex.org/W1998079931","https://openalex.org/W1998971866","https://openalex.org/W2002937040","https://openalex.org/W2008345619","https://openalex.org/W2027417241","https://openalex.org/W2029952427","https://openalex.org/W2038712067","https://openalex.org/W2039071845","https://openalex.org/W2043696829","https://openalex.org/W2056837471","https://openalex.org/W2062967876","https://openalex.org/W2066998725","https://openalex.org/W2068310793","https://openalex.org/W2096950509","https://openalex.org/W2099382478","https://openalex.org/W2108745864","https://openalex.org/W2108861561","https://openalex.org/W2113327188","https://openalex.org/W2114383061","https://openalex.org/W2117419186","https://openalex.org/W2120976579","https://openalex.org/W2122375037","https://openalex.org/W2134607826","https://openalex.org/W2137390717","https://openalex.org/W2138088489","https://openalex.org/W2140932756","https://openalex.org/W2143913849","https://openalex.org/W2159060826","https://openalex.org/W2161821474","https://openalex.org/W2168280552","https://openalex.org/W2168586185","https://openalex.org/W2171749007","https://openalex.org/W2235360349","https://openalex.org/W2329888282","https://openalex.org/W2565774803"],"related_works":["https://openalex.org/W2335120462","https://openalex.org/W2605418410","https://openalex.org/W3004655782","https://openalex.org/W2174033131","https://openalex.org/W2079846804","https://openalex.org/W2885826817","https://openalex.org/W2114843158","https://openalex.org/W4282936581","https://openalex.org/W2062023554","https://openalex.org/W1972615717"],"abstract_inverted_index":{"Abstract":[0],"The":[1,109,196],"development":[2],"of":[3,14,78,104,123,128,140,159,168,211,220,224],"resistance":[4,28,225],"to":[5,21,30,45,51,57,71,83,89,135,187,189,199,226,233],"tyrosine":[6],"kinase":[7],"inhibitors":[8,32],"(TKI)":[9],"limits":[10],"the":[11,23,73,79,84,130,141,151,190,202,208,214,231],"long-term":[12],"efficacy":[13],"cancer":[15,194],"treatments":[16],"involving":[17],"them.":[18],"We":[19],"aimed":[20],"understand":[22],"mechanisms":[24],"that":[25,93,174,228],"underlie":[26],"acquired":[27,133,157,197],"(AR)":[29],"MET":[31,40,206],"in":[33,99,177,192,235],"lung":[34,193],"cancer.":[35],"EBC1":[36],"cells,":[37,92],"which":[38],"have":[39,132,156],"amplification":[41],"and":[42,64,75,102,107,115,145,170,179,183,207],"are":[43],"sensitive":[44],"TKIs":[46],"against":[47],"MET,":[48],"were":[49,69],"used":[50,70],"generate":[52],"multiple":[53],"clones":[54],"with":[55,138,165],"AR":[56,82,188],"a":[58,171],"MET-TKI.":[59],"Whole-exome":[60],"sequencing,":[61,63],"RNA":[62],"global":[65,112],"DNA":[66,113],"methylation":[67],"analysis":[68],"scrutinize":[72],"genetic":[74],"molecular":[76],"characteristics":[77],"resistant":[80,91,124],"cells.":[81,125,195,237],"MET-TKI":[85,227],"involved":[86],"changes":[87,98,176],"common":[88],"all":[90],"is,":[94],"phenotypic":[95],"modifications,":[96],"specific":[97],"gene":[100,110],"expression,":[101,111],"reactivation":[103],"AKT,":[105],"ERK,":[106],"mTOR.":[108],"methylation,":[114],"mutational":[116,172],"profiles":[117],"distinguished":[118],"at":[119],"least":[120],"two":[121],"groups":[122],"In":[126,150],"one":[127],"these,":[129],"cells":[131,155],"sensitivity":[134,198],"erlotinib,":[136],"concomitantly":[137,164],"mutations":[139],"KIRREL,":[142],"HDAC11,":[143],"HIATL1,":[144],"MAPK1IP1L":[146],"genes,":[147],"among":[148],"others.":[149],"other":[152],"group,":[153],"some":[154],"inactivation":[158,219],"neurofibromatosis":[160],"type":[161],"2":[162],"(NF2)":[163],"strong":[166],"overexpression":[167],"NRG1":[169],"profile":[173],"includes":[175],"LMLN":[178],"TOMM34.":[180],"Multiple":[181],"independent":[182],"simultaneous":[184],"strategies":[185],"lead":[186],"MET-TKIs":[191],"erlotinib":[200,234],"supports":[201],"known":[203],"crosstalk":[204],"between":[205],"HER":[209],"family":[210],"receptors.":[212],"For":[213],"first":[215],"time,":[216],"we":[217],"show":[218],"NF2":[221],"during":[222],"acquisition":[223],"may":[229],"explain":[230],"refractoriness":[232],"these":[236],"Mol":[238],"Cancer":[239],"Ther;":[240],"16(7);":[241],"1366\u201376.":[242],"\u00a92017":[243],"AACR.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-04-28T00:00:00"}